Phase 2 Stomach Cancer Trial, Recruiting NCT07354711 Sponsor: 3H Pharmaceuticals Co., Ltd. Condition: Stomach Cancer
Back to Stomach Cancer

Phase 2 Stomach Cancer Trial, Recruiting

NCT07354711
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing and able to sign the consent form and follow the study schedule and requirements.
  • People aged 18 or older at the time of signing the consent form.
  • People who have at least one tumour or lesion that can be measured on a scan, according to standard measurement guidelines (called RECIST v1.1).
  • People who are reasonably active and able to care for themselves, with only mild limitations on daily activities (this is measured using a standard scale called ECOG, with a score of 0 or 1).
  • People with a life expectancy of at least 3 months.

Who may not be able to join:

  • People who have cancer that has spread to the membranes surrounding the brain or spinal cord.
  • People who have uncontrolled fluid build-up around the lungs, heart, or in the abdomen that requires draining every two weeks or more often.
  • People who have taken part in another clinical trial and received an experimental drug within the 4 weeks before starting this study.
  • People who still have side effects from previous cancer treatment that have not improved to a mild level (with some exceptions, such as hair loss or certain other mild side effects that the trial doctor considers low risk).
  • People who have a significant eye condition affecting the cornea or retina — including but not limited to certain types of keratopathy, corneal injury, inflammation, ulceration, or eye surface inflammation — as assessed by the trial doctor (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 0086-21-50895559

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
3H Pharmaceuticals Co., Ltd.
Registry
ClinicalTrials.gov
Start date
4 January 2026
Est. completion
1 January 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Dose Escalation Phase:Number of Participants with Adverse Events (AEs) and Serious Adverse Events (SAEs); Dose Escalation Phase:Maximum Tolerated Dose (MTD) or Maximum Administered Dose (MAD) of 3H-10000; Dose Escalation Phase:The recommended Phase 2 dose (RP2D) of 3H-10000; Efficacy Expansion Phase:Overall Response Rate (ORR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov